At the same time, CD38 deficiency reduced oxidative stress damage by decreasing MDA formation and increasing SOD activity in vivo and in vitro, preventing the further development of NAFLD. This evidence concerns the gene CD38 and metabolic dysfunction-associated steatotic liver disease.